{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T04:38:51Z","timestamp":1790829531827,"version":"4.1.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Cell Int"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/s12935-014-0132-6","type":"journal-article","created":{"date-parts":[[2014,12,11]],"date-time":"2014-12-11T17:49:03Z","timestamp":1418320143000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Osteoblast inhibition by chemokine cytokine ligand3 in myeloma-induced bone disease"],"prefix":"10.1186","volume":"14","author":[{"given":"Rong","family":"Fu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sijie","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erbao","family":"Ruan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guojin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaquan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zonghong","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,12,12]]},"reference":[{"issue":"4","key":"132_CR1","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/j.1600-0609.1992.tb00046.x","volume":"49","author":"T Taube","year":"1992","unstructured":"Taube T, Beneton MNC, McCloskey EV, Rogers S, Greaves M, Kanis JA: Abnormal bone remodeling in patients with myelomatosis and normal biochemical indices of bone resorption[J]. Eur J Haematol. 1992, 49 (4): 192-198. 10.1111\/j.1600-0609.1992.tb00046.x.","journal-title":"Eur J Haematol"},{"key":"132_CR2","first-page":"83","volume-title":"Cancer Treatment and Research Volume 118","author":"GD Roodman","year":"2004","unstructured":"Roodman GD, Choi SJ: MIP-1 Alpha and Myeloma Bone Disease. In The Biology of Skeletal Metastases. Cancer Treatment and Research Volume 118. Edited by: Keller ET, Leland WK C. 2004, Springer, US, 83-100. 2,","edition":"2"},{"issue":"1","key":"132_CR3","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1046\/j.1365-2141.2003.04561.x","volume":"123","author":"E Terpos","year":"2003","unstructured":"Terpos E, Politou M, Szydlo R, Goldman JM, Apperley JF, Rahemtulla A: Serum levels of macrophage inflammatory protein - 1 alpha (MIP - 1\u03b1) correlate with the extent of bone disease and survival in patients with multiple myeloma[J]. Br J Haematol. 2003, 123 (1): 106-109. 10.1046\/j.1365-2141.2003.04561.x.","journal-title":"Br J Haematol"},{"issue":"7","key":"132_CR4","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1080\/10428190500066636","volume":"46","author":"H Hata","year":"2005","unstructured":"Hata H: Bone lesions and macrophage inflammatory protein-1 alpha (MIP-1\u03b1) in human multiple myeloma[J]. Leuk Lymphoma. 2005, 46 (7): 967-972. 10.1080\/10428190500066636.","journal-title":"Leuk Lymphoma"},{"issue":"11","key":"132_CR5","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1038\/sj.leu.2403486","volume":"18","author":"S Lentzsch","year":"2004","unstructured":"Lentzsch S, Chatterjee M, Gries M, Bommert K, Gollasch H, Dorken B, Bargou RC: PI3-K\/AKT\/FKHR and MAPK signaling cascades are redundantly stimulated by a variety of cytokines and contribute independently to proliferation and survival of multiple myeloma cells[J]. Leukemia. 2004, 18 (11): 1883-1890. 10.1038\/sj.leu.2403486.","journal-title":"Leukemia"},{"issue":"9","key":"132_CR6","doi-asserted-by":"crossref","first-page":"3568","DOI":"10.1182\/blood-2002-08-2383","volume":"101","author":"S Lentzsch","year":"2003","unstructured":"Lentzsch S, Gries M, Janz M, Bargou R, Dorken B, Mapara MY: Macrophage inflammatory protein 1-alpha (MIP-1\u03b1) triggers migration and signaling cascades mediating survival and proliferation in multiple myeloma (MM) cells[J]. Blood. 2003, 101 (9): 3568-3573. 10.1182\/blood-2002-08-2383.","journal-title":"Blood"},{"issue":"2","key":"132_CR7","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.bbrc.2005.09.146","volume":"338","author":"U Heider","year":"2005","unstructured":"Heider U, Hofbauer LC, Zavrski I, Kaiser M, Jakob C, Sezer O: Novel aspects of osteoclast activation and osteoblast inhibition in myeloma bone disease[J]. Biochem Biophys Res Commun. 2005, 338 (2): 687-693. 10.1016\/j.bbrc.2005.09.146.","journal-title":"Biochem Biophys Res Commun"},{"issue":"11","key":"132_CR8","doi-asserted-by":"crossref","first-page":"3349","DOI":"10.1182\/blood.V97.11.3349","volume":"97","author":"JH Han","year":"2001","unstructured":"Han JH, Choi SJ, Kurihara N, Koide M, Oba Y, Roodman GD: Macrophage inflammatory protein-1\u03b1 is an osteoclastogenic factor in myeloma that is independent of receptor activator of nuclear factor \u03baB ligand[J]. Blood. 2001, 97 (11): 3349-3353. 10.1182\/blood.V97.11.3349.","journal-title":"Blood"},{"issue":"19","key":"132_CR9","doi-asserted-by":"crossref","first-page":"6081","DOI":"10.1158\/1078-0432.CCR-08-0219","volume":"14","author":"F Silvestris","year":"2008","unstructured":"Silvestris F, Cafforio P, De Matteo M, Calvani N, Frassanito MA, Dammacco F: Negative regulation of the osteoblast function in multiple myeloma through the repressor gene E4BP4 activated by malignant plasma cells[J]. Clin Cancer Res. 2008, 14 (19): 6081-6091. 10.1158\/1078-0432.CCR-08-0219.","journal-title":"Clin Cancer Res"},{"issue":"2","key":"132_CR10","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.leukres.2006.04.014","volume":"31","author":"F Silvestris","year":"2007","unstructured":"Silvestris F, Lombardi L, De Matteo M, Bruno A, Dammacco F: Myeloma bone disease: pathogenetic mechanisms and clinical assessment[J]. Leuk Res. 2007, 31 (2): 129-138. 10.1016\/j.leukres.2006.04.014.","journal-title":"Leuk Res"},{"issue":"2","key":"132_CR11","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.bcmd.2004.01.001","volume":"32","author":"GD Roodman","year":"2004","unstructured":"Roodman GD: Pathogenesis of myeloma bone disease[J]. Blood Cell Mol Dis. 2004, 32 (2): 290-292. 10.1016\/j.bcmd.2004.01.001.","journal-title":"Blood Cell Mol Dis"},{"key":"132_CR12","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/1475-2867-14-62","volume":"14","author":"R Fu","year":"2014","unstructured":"Fu R, Gao S, Peng F, Li J, Liu H, Wang H, Xing L, Shao Z: Relationship between abnormal osteoblasts and cellular immunity in multiple myeloma. Cancer Cell International. 2014, 14: 62-10.1186\/1475-2867-14-62. doi:10.1186\/1475-2867-14-62","journal-title":"Cancer Cell International"},{"issue":"4","key":"132_CR13","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.bone.2007.12.006","volume":"42","author":"YW Qiang","year":"2008","unstructured":"Qiang YW, Barlogie B, Rudikoff S, Shaughnessy JD: Dkk1-induced inhibition of Wnt signaling in osteoblast differentiation is an underlying mechanism of bone loss in multiple myeloma[J]. Bone. 2008, 42 (4): 669-680. 10.1016\/j.bone.2007.12.006.","journal-title":"Bone"},{"issue":"1","key":"132_CR14","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1359\/JBMR.041016","volume":"20","author":"YH Wang","year":"2005","unstructured":"Wang YH, Liu Y, Buhl K, Rowe DW: Comparison of the Action of Transient and Continuous PTH on Primary Osteoblast Cultures Expressing Differentiation Stage\u2010Specific GFP[J]. J Bone Miner Res. 2005, 20 (1): 5-14. 10.1359\/JBMR.041016.","journal-title":"J Bone Miner Res"},{"key":"132_CR15","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/324615a0","volume":"324","author":"S Green","year":"1986","unstructured":"Green S, Chambon P: Carcinogenesis: a superfamily of potentially oncogenic hormone receptors[J]. Nature. 1986, 324: 615-617. 10.1038\/324615a0.","journal-title":"Nature"},{"issue":"1","key":"132_CR16","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/j.1749-6632.1975.tb29287.x","volume":"258","author":"MJ Barnes","year":"1975","unstructured":"Barnes MJ: Function of ascorbic acid in collagen metabolism[J]. Ann N Y Acad Sci. 1975, 258 (1): 264-277. 10.1111\/j.1749-6632.1975.tb29287.x.","journal-title":"Ann N Y Acad Sci"},{"issue":"3","key":"132_CR17","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/BF02556874","volume":"38","author":"CG Bellows","year":"1986","unstructured":"Bellows CG, Aubin JE, Heersche JN, Antosz ME: Mineralized bone nodules formedin vitro from enzymatically released rat calvaria cell populations[J]. Calcif Tissue Int. 1986, 38 (3): 143-154. 10.1007\/BF02556874.","journal-title":"Calcif Tissue Int"},{"issue":"11","key":"132_CR18","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1007\/BF02619629","volume":"20","author":"RE Anderson","year":"1984","unstructured":"Anderson RE, Kemp JW, Jee WS, Woodbury DM: Ion-transporting ATPases and matrix mineralization in cultured osteoblastlike cells[J]. In Vitro. 1984, 20 (11): 837-846. 10.1007\/BF02619629.","journal-title":"In Vitro"},{"issue":"12","key":"132_CR19","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1200\/JCO.1989.7.12.1909","volume":"7","author":"R Bataille","year":"1989","unstructured":"Bataille R, Chappard D, Marcelli C, Dessauw P, Sany J, Baldet P, Alexandre C: Mechanisms of bone destruction in multiple myeloma: the importance of an unbalanced process in determining the severity of lytic bone disease[J]. J Clin Oncol. 1989, 7 (12): 1909-1914.","journal-title":"J Clin Oncol"},{"issue":"1","key":"132_CR20","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1046\/j.1365-2141.2003.04374.x","volume":"122","author":"F Silvestris","year":"2003","unstructured":"Silvestris F, Cafforio P, Tucci M, Grinello D, Dammacco F: Upregulation of osteoblast apoptosis by malignant plasma cells: a role in myeloma bone disease[J]. Br J Haematol. 2003, 122 (1): 39-52. 10.1046\/j.1365-2141.2003.04374.x.","journal-title":"Br J Haematol"},{"issue":"11","key":"132_CR21","doi-asserted-by":"crossref","first-page":"6065","DOI":"10.4049\/jimmunol.154.11.6065","volume":"154","author":"K Fuller","year":"1995","unstructured":"Fuller K, Owens JM, Chambers TJ: Macrophage inflammatory protein-1 alpha and IL-8 stimulate the motility but suppress the resorption of isolated rat osteoclasts[J]. J Immunol. 1995, 154 (11): 6065-6072.","journal-title":"J Immunol"},{"issue":"3","key":"132_CR22","first-page":"399","volume":"76","author":"T Kukita","year":"1997","unstructured":"Kukita T, Nomiyama H, Ohmoto Y, Kukita A, Shuto T, Hotokebuchi T, Sugioka Y, Miura R, Iijima T: Macrophage inflammatory protein-1 alpha (LD78) expressed in human bone marrow: its role in regulation of hematopoiesis and osteoclast recruitment[J]. Laboratory Invest. 1997, 76 (3): 399-406.","journal-title":"Laboratory Invest"},{"issue":"1\u20132","key":"132_CR23","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s11010-007-9485-7","volume":"304","author":"M Tsubaki","year":"2007","unstructured":"Tsubaki M, Kato C, Manno M, Ogaki M, Satou T, Itoh T, Kusunoki T, Tanimori Y, Fujiwara K, Matsuoka H, Nishida S: Macrophage inflammatory protein-1\u03b1 (MIP-1\u03b1) enhances a receptor activator of nuclear factor \u03baB ligand (RANKL) expression in mouse bone marrow stromal cells and osteoblasts through MAPK and PI3K\/Akt pathways[J]. Mol Cell Biochem. 2007, 304 (1\u20132): 53-60. 10.1007\/s11010-007-9485-7.","journal-title":"Mol Cell Biochem"},{"issue":"1","key":"132_CR24","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1146\/annurev.cellbio.16.1.191","volume":"16","author":"BR Olsen","year":"2000","unstructured":"Olsen BR, Reginato AM, Wang W: Bone development[J]. Annu Rev Cell Dev Biol. 2000, 16 (1): 191-220. 10.1146\/annurev.cellbio.16.1.191.","journal-title":"Annu Rev Cell Dev Biol"},{"issue":"7","key":"132_CR25","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1038\/leu.2011.43","volume":"25","author":"S Vallet","year":"2011","unstructured":"Vallet S, Pozzi S, Patel K, Vaghela N, Fulciniti MT, Veiby P, Hideshima T, Santo L, Cirstea D, Scadden DT, Anderson KC, Raje N: A novel role for CCL3 (MIP-1\u03b1) in myeloma-induced bone disease via osteocalcin downregulation and inhibition of osteoblast function[J]. Leukemia. 2011, 25 (7): 1174-1181. 10.1038\/leu.2011.43.","journal-title":"Leukemia"},{"key":"132_CR26","doi-asserted-by":"crossref","first-page":"898","DOI":"10.2741\/2730","volume":"13","author":"T Komori","year":"2007","unstructured":"Komori T: Regulation of bone development and maintenance by Runx2[J]. Front Biosci: a journal and virtual library. 2007, 13: 898-903. 10.2741\/2730.","journal-title":"Front Biosci: a journal and virtual library"},{"key":"132_CR27","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.gene.2005.12.022","volume":"372","author":"Y Nishio","year":"2006","unstructured":"Nishio Y, Dong Y, Paris M, O\u2019Keefe RJ, Schwarz EM, Drissi H: Runx2-mediated regulation of the zinc finger Osterix\/Sp7 gene[J]. Gene. 2006, 372: 62-70. 10.1016\/j.gene.2005.12.022.","journal-title":"Gene"},{"key":"132_CR28","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.gene.2004.05.026","volume":"341","author":"Y Gao","year":"2004","unstructured":"Gao Y, Jheon A, Nourkeyhani H, Kobayashi H, Ganss B: Molecular cloning, structure, expression, and chromosomal localization of the human Osterix (SP7) gene[J]. Gene. 2004, 341: 101-110. 10.1016\/j.gene.2004.05.026.","journal-title":"Gene"},{"issue":"5","key":"132_CR29","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.devcel.2005.02.013","volume":"8","author":"TP Hill","year":"2005","unstructured":"Hill TP, Sp\u00e4ter D, Taketo MM, Birchmeier W, Hartmann C: Canonical Wnt\/\u03b2-catenin signaling prevents osteoblasts from differentiating into chondrocytes[J]. Dev Cell. 2005, 8 (5): 727-738. 10.1016\/j.devcel.2005.02.013.","journal-title":"Dev Cell"},{"issue":"5","key":"132_CR30","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.devcel.2005.02.017","volume":"8","author":"DA Glass II","year":"2005","unstructured":"Glass DA, Bialek P, Ahn JD, Starbuck M, Patel MS, Clevers H, Taketo MM, Long F, McMahon AP, Lang RA, Karsenty G: Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation[J]. Dev Cell. 2005, 8 (5): 751-764. 10.1016\/j.devcel.2005.02.017.","journal-title":"Dev Cell"},{"issue":"39","key":"132_CR31","doi-asserted-by":"crossref","first-page":"33132","DOI":"10.1074\/jbc.M500608200","volume":"280","author":"T Gaur","year":"2005","unstructured":"Gaur T, Lengner CJ, Hovhannisyan H, Bhat RA, Bodine PV, Komm BS, Javed A, van Wijnen AJ, Stein JL, Stein GS, Lian JB: Canonical WNT signaling promotes osteogenesis by directly stimulating Runx2 gene expression[J]. J Biol Chem. 2005, 280 (39): 33132-33140. 10.1074\/jbc.M500608200.","journal-title":"J Biol Chem"}],"container-title":["Cancer Cell International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-014-0132-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12935-014-0132-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-014-0132-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,30]],"date-time":"2023-07-30T16:17:11Z","timestamp":1690733831000},"score":1,"resource":{"primary":{"URL":"http:\/\/cancerci.biomedcentral.com\/articles\/10.1186\/s12935-014-0132-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["132"],"URL":"https:\/\/doi.org\/10.1186\/s12935-014-0132-6","relation":{},"ISSN":["1475-2867"],"issn-type":[{"value":"1475-2867","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12]]},"article-number":"132"}}